Showing 1071-1080 of 8196 results for "".
Prospective Analysis: PRP Post-Mohs; Physician Debt Insights
https://practicaldermatology.com/youngmd-connect/resident-resource-center/propsective-analysis-prp-post-mohs-physician-debt-insights/23038/The Showdown: Smartphone vs. DSLR Cameras
https://practicaldermatology.com/topics/practice-management/the-showdown-smartphone-vs-dslr-cameras/23031/Consistently capturing great photos can have a huge impact on your practice. Here’s what to consider.Ortho Dermatologics NDA, J&J Innovation, Consumer Credit Insights
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-ortho-dermatologics-nda-j-j-innovation-consumer-credit-insights/18395/Two-thirds of prospective patients say they would be more likely to book a procedure if they were aware of financing options. More than three-quarters of prospective patients are unaware of financing options, according to a recent survey by Zalea. In conjunction with Johnson & Johnson Consumer,Best-in-Class At-Home Beauty Devices for Dermatologists
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/best-in-class-at-home-beauty-devices-for-dermatologists/20724/An experience-based assessment of a growing market segment.Moisturizers for Skin Diseases: New Insights
https://practicaldermatology.com/topics/atopic-dermatitis/moisturizers-for-skin-diseases-new-insights/22977/Prednisone-induced DRESS Syndrome
https://practicaldermatology.com/topics/general-topics/prednisone-induced-dress-syndrome/21572/This unusual reaction was resolved with a switch to a Group C steroid.How To Influence Others, Dermatology Practice-Style
https://practicaldermatology.com/topics/practice-management/how-to-influence-others-dermatology-practice-style/23963/Influence means “to have an effect on the behavior of someone or something.”DermWireTV: Opzelura for Vitiligo; Biosimilars Boom; Updates from BTL and Cynosure; DIS Launch
https://practicaldermatology.com/topics/psoriasis/dermwiretv-opzelura-for-vitiligo-biosimilars-boom-updates-from-btl-and-cynosure-dis-launch/20109/FDA has approved Opzelura (ruxolitinib cream 1.5%, Incyte) for the topical treatment of nonsegmental vitiligo in adult and pediatric patients 12 years of age and older. Analysts predict that use of biosimilars in the US is about to increase significantly as Humira (adalimumab, AbbVie) faces patent eDiversity and Inclusion in Dermatology: The Impact of Systemic Racism in Dermatology and Opportunities for Change
https://practicaldermatology.com/issues/supplements/diversity-and-inclusion-in-dermatology-the-impact-of-systemic-racism-in-dermatology-and-opportunities-for-change/23474/Diversity and Equity in Dermatology
https://practicaldermatology.com/topics/practice-management/diversity-and-equity-in-dermatology/23456/